Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles

Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid cl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yashna Chabria, Garry P. Duffy, Aoife J Lowery, Róisín M. Dwyer
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/0712083151174e13ab19ca0c45c5b6e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0712083151174e13ab19ca0c45c5b6e1
record_format dspace
spelling oai:doaj.org-article:0712083151174e13ab19ca0c45c5b6e12021-11-25T16:50:54ZHydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles10.3390/biomedicines91116942227-9059https://doaj.org/article/0712083151174e13ab19ca0c45c5b6e12021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1694https://doaj.org/toc/2227-9059Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid clearance from the body and limited efficacy remain a major challenge. This highlights the need for a local sustained delivery system for nanoparticles (NPs) and extracellular vesicles (EVs) at the target site that will ensure prolonged exposure, maximum efficacy and dose, and minimal toxicity. Biocompatible hydrogels loaded with therapeutic NPs/EVs hold immense promise as cell-free sustained and targeted delivery systems in a range of disease settings. These bioscaffolds ensure retention of the nano-sized particles at the target site and can also act as controlled release systems for therapeutics over a prolonged period of time. The encapsulation of stimuli sensitive components into hydrogels supports the release of the content on-demand. In this review, we highlight the prospect of the sustained and prolonged delivery of these nano-sized therapeutic entities from hydrogels for broad applications spanning tissue regeneration and cancer treatment. Further understanding of the parameters controlling the release rate of these particles and efficient transfer of cargo to target cells will be fundamental to success.Yashna ChabriaGarry P. DuffyAoife J LoweryRóisín M. DwyerMDPI AGarticlenanoparticlesextracellular vesicleshydrogelsbiocompatiblebioscaffoldstissue regenerationBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1694, p 1694 (2021)
institution DOAJ
collection DOAJ
language EN
topic nanoparticles
extracellular vesicles
hydrogels
biocompatible
bioscaffolds
tissue regeneration
Biology (General)
QH301-705.5
spellingShingle nanoparticles
extracellular vesicles
hydrogels
biocompatible
bioscaffolds
tissue regeneration
Biology (General)
QH301-705.5
Yashna Chabria
Garry P. Duffy
Aoife J Lowery
Róisín M. Dwyer
Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
description Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid clearance from the body and limited efficacy remain a major challenge. This highlights the need for a local sustained delivery system for nanoparticles (NPs) and extracellular vesicles (EVs) at the target site that will ensure prolonged exposure, maximum efficacy and dose, and minimal toxicity. Biocompatible hydrogels loaded with therapeutic NPs/EVs hold immense promise as cell-free sustained and targeted delivery systems in a range of disease settings. These bioscaffolds ensure retention of the nano-sized particles at the target site and can also act as controlled release systems for therapeutics over a prolonged period of time. The encapsulation of stimuli sensitive components into hydrogels supports the release of the content on-demand. In this review, we highlight the prospect of the sustained and prolonged delivery of these nano-sized therapeutic entities from hydrogels for broad applications spanning tissue regeneration and cancer treatment. Further understanding of the parameters controlling the release rate of these particles and efficient transfer of cargo to target cells will be fundamental to success.
format article
author Yashna Chabria
Garry P. Duffy
Aoife J Lowery
Róisín M. Dwyer
author_facet Yashna Chabria
Garry P. Duffy
Aoife J Lowery
Róisín M. Dwyer
author_sort Yashna Chabria
title Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_short Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_full Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_fullStr Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_full_unstemmed Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_sort hydrogels: 3d drug delivery systems for nanoparticles and extracellular vesicles
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/0712083151174e13ab19ca0c45c5b6e1
work_keys_str_mv AT yashnachabria hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
AT garrypduffy hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
AT aoifejlowery hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
AT roisinmdwyer hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
_version_ 1718412876980420608